Expert Video - What is 'comprehensive biomarker testing' and why is it important in lung cancer?
Robert Winn, MD, of the Virginia Commonwealth University Massey Cancer Center, explains what biomarkers are, how they were first discovered, and how they can predict cancer risk and help determine treatment. He describes the history of lung cancer treatment and how understanding biomarkers can help doctors prescribe the most effective lung cancer treatment.
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
This educational activity has been developed by
A Breath of Hope Lung Foundation and Mechanisms in Medicine Inc.
This activity is supported by educational grants from AstraZeneca Pharmaceuticals, Bristol-Myers Squibb Foundation Inc., Bristol-Myers Squibb Grants and Giving, Foundation Medicine, Genentech, Jazz Pharmaceuticals, Merck Sharp & Dohme LLC, Neogenomics, Novartis, Pfizer, and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.